None listed
Conditions
Interventions
Intervention1: Study drug: Capsule to be taken once daily for 21days
Control Intervention1: Placebo: Capsule to be taken once daily for 21days
Sponsors
Aurea Biolabs P Ltd
Eligibility
Inclusion criteria
Inclusion criteria: a. Subjects aged between 18 to 40 years and in good health. b. Subjects not taking any drugs or medications (excluding the contraceptives) c. Nonsmokers d. Subjects must refrain from caffeine or alcohol for at least 12 hours prior to testing.
Exclusion criteria
Exclusion criteria: 1. Subjects using nutritional supplements for cognitive function 2 weeks prior to enrolling in study 2. Subjects affected by Attention Deficit or other related disorders, psychiatric or neurological diseases (including aphasia, sensory, motor or visual disturbances which could affect test results) and subjects diagnosed with anxiety or depression. 3. Subjects with mental disabilities 4. Subjects with head injuries. 5. Subjects with medical conditions such as diabetes, hypoglycemia, psychiatric disorders, epilepsy, gastrointestinal disorders, cancer, coagulation disorders, cardiovascular, lung, kidney, thyroid, liver diseases, excessive consumption of alcohol or substance abuse/dependence. 6. Subjects taking Coumadin, tricyclic, antidepressants, antipsychotics, and anticonvulsants or subjects already taking medications for cognitive functioning. 7. Subjects who are pregnant or lactating or who plan to become pregnant.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| â?¢ Compare Cognitive Battery Test - Cambridge Neuropsychological Test Automated Battery (CANTAB) from to end of study â?¢ Monitoring of Adverse Event. Timepoint: day1 day21 | — |
Secondary
| Measure | Time frame |
|---|---|
| Compare Cognitive Battery Test - Cambridge Neuropsychological TestTimepoint: day1 day21 | — |
Countries
India
Contacts
Public ContactDivya C
BioAgile Therapeutics Pvt Ltd
Outcome results
None listed